Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies
- 3 April 2021
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (8), 514-525
- https://doi.org/10.1016/j.clml.2021.03.012
Abstract
No abstract availableFunding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 41 references indexed in Scilit:
- Therapeutic interventions for Burkitt lymphoma in childrenEmergencias, 2011
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectBlood, 2009
- Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study*British Journal of Haematology, 2008
- A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution studyAnnals of Oncology, 2006
- Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemiaCancer, 2006
- Adult Burkitt leukemia and lymphomaBlood, 2004
- Modified Magrath Regimens for Adults with Burkitt and Burkitt-Like Lymphomas: Preserved Efficacy with Decreased ToxicityLeukemia & Lymphoma, 2004
- The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemiaBlood, 2001
- P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell linesInternational Journal of Cancer, 1991